Literature DB >> 7591263

Implication of the alpha v beta 3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1.

F Carreiras1, M Lehmann, F Sichel, J Marvaldi, P Gauduchon, J Y Le Talaer.   

Abstract

Accumulating evidence suggests that integrins, which participate in many complex cellular processes, are important for tumor progression and metastasis. In order to understand the role of these cell-surface receptors and of their ligands in the biological behavior of ovarian tumor cells, we have examined the expression of integrins in the human ovarian-adenocarcinoma cell line IGROV1. These cells expressed the alpha v sub-unit and used it to attach on vitronectin (Vn). A monoclonal antibody (MAb) (69-6-5) specific to alpha v blocked the attachment of IGROV1 cells on Vn and fibrinogen (Fg), but not on fibronectin (FN) and other adhesive ligands. Immunoprecipitation of surface biotinylated cells followed by Western blotting showed that the alpha v sub-unit was associated with beta 3, but not with beta 1, beta 5 or beta 6. When cells were cultivated on glass coverslips or on Vn sub-stratum in serum-free medium, immunofluorescence staining with MAb 69-6-5 revealed the presence of alpha v at cell-cell contacts and at focal contacts, supporting its active participation in adhesion as part of a functional heterodimer. Furthermore, immunofluorescence data showed the presence of Vn as a fibrillar network in IGROV1 cells cultivated on FN-coated slides. These results suggest that alpha v beta 3 and its Vn ligand may play a important role in the behavior of ovarian epithelial tumors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591263     DOI: 10.1002/ijc.2910630413

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study.

Authors:  Nicolas Aide; Mélanie Briand; Pierre Bohn; Soizic Dutoit; Charline Lasnon; Jacques Chasle; Jean Rouvet; Romain Modzelewski; Antony Vela; Edwiges Deslandes; Pierre Vera; Laurent Poulain; Franck Carreiras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-30       Impact factor: 9.236

2.  Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.

Authors:  Neveen Said; Ida Najwer; Kouros Motamed
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

3.  Novel immunohistochemical marker, integrin α(V)β(3), for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis.

Authors:  Tsukasa Kitahashi; Mitsuyoshi Yoshimoto; Toshio Imai
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

4.  Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.

Authors:  Yifei Wang; Juanjuan Liu; Bei Lin; Changzhi Wang; Quanrong Li; Shuice Liu; Limei Yan; Shulan Zhang; Masao Iwamori
Journal:  Int J Mol Sci       Date:  2011-05-27       Impact factor: 5.923

5.  Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.

Authors:  Deep Pokharel; Matthew P Padula; Jamie F Lu; Jessica L Tacchi; Frederick Luk; Steven P Djordjevic; Mary Bebawy
Journal:  J Extracell Vesicles       Date:  2014-08-22

Review 6.  Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.

Authors:  Nina Sluiter; Erienne de Cuba; Riom Kwakman; Geert Kazemier; Gerrit Meijer; Elisabeth Atie Te Velde
Journal:  Clin Exp Metastasis       Date:  2016-04-13       Impact factor: 5.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.